From trauma to transmission: exploring the intersection of adversity, substance use, and HIV risk in women's life histories.


Journal

International journal for equity in health
ISSN: 1475-9276
Titre abrégé: Int J Equity Health
Pays: England
ID NLM: 101147692

Informations de publication

Date de publication:
01 09 2023
Historique:
received: 27 05 2023
accepted: 21 08 2023
medline: 4 9 2023
pubmed: 2 9 2023
entrez: 1 9 2023
Statut: epublish

Résumé

At increased risk for poor health outcomes, physical and/or sexual violence, and onward transmission of HIV, women who use drugs and are living with HIV (WWUDHIV) are vulnerable and in need of services. Understanding the role of trauma across their life history may offer insights into HIV and drug use prevention and opportunities for intervention. We explored trauma and drug use among WWUDHIV in Dar es Salaam, Tanzania. We conducted in-depth interviews with 30 WWUDHIV from January-March 2019. Interviewers used semi-structured interview guides and asked questions about the life history as related to drug use. Interviews were audio recorded, transcribed, translated, coded, and life histories charted. We utilized content analysis. Participants described death of family members as traumatic catalysts for drug use. Sexual partners early in their life history were often the point of introduction to drugs and source of HIV acquisition. Death of partners was present across many life histories and was a traumatic event negatively influencing life trajectories, including start of sex work for survival or to support drug use. Sex work in-turn often led to traumatic events including sexual and/or physical violence. HIV diagnosis for many participants followed the start of drug use, frequently occurred during pregnancy or severe illness and was described by most participants as a trauma. Despite this, particularly during pregnancy, HIV diagnosis was a turning point for some participant's desire to engage in drug use treatment. Traumatic events were often cumulative and regularly described as catalysts for poor mental health that could lead to new or increased drug use for coping. These findings suggest trauma is common in the life history of WWUDHIV and has negative impacts on drug use and HIV vulnerability. Our life history charting highlights the cumulative and cyclical nature of trauma and drug use in this population. This study allows for better understanding of trauma, drug use, and HIV prevention, which offers opportunities for intervention among a group with limited access to services: during adolescence for orphaned youth, following the death of a child or partner, and when vulnerable women engage with the health system (HIV diagnosis, pregnancy, illness).

Sections du résumé

BACKGROUND
At increased risk for poor health outcomes, physical and/or sexual violence, and onward transmission of HIV, women who use drugs and are living with HIV (WWUDHIV) are vulnerable and in need of services. Understanding the role of trauma across their life history may offer insights into HIV and drug use prevention and opportunities for intervention. We explored trauma and drug use among WWUDHIV in Dar es Salaam, Tanzania.
METHODS
We conducted in-depth interviews with 30 WWUDHIV from January-March 2019. Interviewers used semi-structured interview guides and asked questions about the life history as related to drug use. Interviews were audio recorded, transcribed, translated, coded, and life histories charted. We utilized content analysis.
RESULTS
Participants described death of family members as traumatic catalysts for drug use. Sexual partners early in their life history were often the point of introduction to drugs and source of HIV acquisition. Death of partners was present across many life histories and was a traumatic event negatively influencing life trajectories, including start of sex work for survival or to support drug use. Sex work in-turn often led to traumatic events including sexual and/or physical violence. HIV diagnosis for many participants followed the start of drug use, frequently occurred during pregnancy or severe illness and was described by most participants as a trauma. Despite this, particularly during pregnancy, HIV diagnosis was a turning point for some participant's desire to engage in drug use treatment. Traumatic events were often cumulative and regularly described as catalysts for poor mental health that could lead to new or increased drug use for coping.
CONCLUSIONS
These findings suggest trauma is common in the life history of WWUDHIV and has negative impacts on drug use and HIV vulnerability. Our life history charting highlights the cumulative and cyclical nature of trauma and drug use in this population. This study allows for better understanding of trauma, drug use, and HIV prevention, which offers opportunities for intervention among a group with limited access to services: during adolescence for orphaned youth, following the death of a child or partner, and when vulnerable women engage with the health system (HIV diagnosis, pregnancy, illness).

Identifiants

pubmed: 37658358
doi: 10.1186/s12939-023-01994-4
pii: 10.1186/s12939-023-01994-4
pmc: PMC10474777
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

174

Subventions

Organisme : NIDA NIH HHS
ID : K01 DA047142
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI094189
Pays : United States
Organisme : NIH HHS
ID : K01DA047142
Pays : United States

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

BMC Psychiatry. 2017 May 4;17(1):164
pubmed: 28472931
PLoS Med. 2018 Dec 11;15(12):e1002680
pubmed: 30532209
Matern Child Health J. 2014 Feb;18(2):344-65
pubmed: 23975451
Psychol Trauma. 2013 Mar 1;52(2):110-118
pubmed: 23542882
J Int AIDS Soc. 2013 Mar 04;16:17980
pubmed: 23462140
Vulnerable Child Youth Stud. 2017;12(3):258-263
pubmed: 30090121
J Acquir Immune Defic Syndr. 2015 Jun 1;69 Suppl 2:S100-9
pubmed: 25978476
AIDS Patient Care STDS. 2020 Jun;34(6):275-280
pubmed: 32484742
Curr HIV/AIDS Rep. 2015 Dec;12(4):397-405
pubmed: 26419376
SSM Qual Res Health. 2021 Dec;1:
pubmed: 35174337
Curr HIV/AIDS Rep. 2016 Dec;13(6):374-382
pubmed: 27704251
PLoS Med. 2020 Sep 15;17(9):e1003297
pubmed: 32931504
Drug Alcohol Depend. 2019 May 1;198:80-86
pubmed: 30884432
Psychosomatics. 2015 Mar-Apr;56(2):107-18
pubmed: 25597836
MMWR Morb Mortal Wkly Rep. 2018 Jun 15;67(23):663-667
pubmed: 29902168
Clin Psychol (New York). 2012 Sep;19(3):260-275
pubmed: 25762853
Arch Public Health. 2022 Mar 9;80(1):74
pubmed: 35260189
Lancet. 2016 Oct 8;388(10053):1603-1658
pubmed: 27733283
Subst Abuse Treat Prev Policy. 2013 Oct 01;8:35
pubmed: 24079946
Lancet. 2008 Nov 15;372(9651):1733-45
pubmed: 18817968
J Homosex. 2021 Jan 28;68(2):336-357
pubmed: 31469348
Soc Sci Med. 2021 Jan;268:113379
pubmed: 32979773
J Trauma Dissociation. 2015;16(2):153-69
pubmed: 25587939
Drug Alcohol Depend. 2020 Oct 1;215:108218
pubmed: 32916450
AIDS Care. 2009 Aug;21(8):1032-41
pubmed: 20024760
PLoS One. 2021 Jun 22;16(6):e0252747
pubmed: 34157025
Afr Health Sci. 2021 Jun;21(2):593-602
pubmed: 34795712
AIDS Behav. 2017 Sep;21(9):2670-2681
pubmed: 28176167
PLoS One. 2019 Nov 19;14(11):e0219032
pubmed: 31743336
Addiction. 2008 Jan;103(1):91-100
pubmed: 18081614
Am J Trop Med Hyg. 2008 Sep;79(3):338-43
pubmed: 18784224
Front Reprod Health. 2023 Jan 18;4:1089663
pubmed: 36743824
Harm Reduct J. 2020 Jul 31;17(1):53
pubmed: 32736624
Curr Addict Rep. 2018 Dec;5(4):428-453
pubmed: 32494564
Am J Public Health. 2014 May;104(5):e42-54
pubmed: 24625169
Depress Anxiety. 2010 Dec;27(12):1077-86
pubmed: 21049532
Addict Sci Clin Pract. 2011 Jul;6(1):44-55
pubmed: 22003421
Monogr Soc Res Child Dev. 2011 Dec;76(4):147-162
pubmed: 25125708
Addict Sci Clin Pract. 2023 Mar 27;18(1):19
pubmed: 36973794
Public Health Rev. 2017 Dec 05;38:28
pubmed: 29450099
Glob Public Health. 2022 Feb;17(2):254-284
pubmed: 33301704
Pediatrics. 2022 May 1;149(Suppl 5):
pubmed: 35503318
Harm Reduct J. 2020 Mar 24;17(1):18
pubmed: 32209110
J Adolesc. 2012 Oct;35(5):1329-40
pubmed: 22704785
Psychoanal Study Child. 1963;18:286-306
pubmed: 14147282
Sex Transm Dis. 2017 Feb;44(2):79-84
pubmed: 27984553
Front Psychol. 2023 Jan 27;13:1028375
pubmed: 36778165
Drug Alcohol Depend. 2007 Jan 5;86(1):1-21
pubmed: 16759822
Arch Pediatr Adolesc Med. 2010 Jan;164(1):9-15
pubmed: 20048236
Soc Sci Med. 2002 Jan;54(2):179-92
pubmed: 11824924

Auteurs

Nora S West (NS)

Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA. Nora.West@ucsf.edu.

Frank Kussaga (F)

Internal/Preventive Medicine, Griffin Hospital, Derby, CT, USA.

Alex Rittenhouse (A)

Department of Environmental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Johns Hopkins University School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Brenice Duroseau (B)

School of Nursing, Johns Hopkins University, Baltimore, MD, USA.

Deja Knight (D)

Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Jessie Mbwambo (J)

Department of Psychiatry and Mental Health, School of Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.

Samuel Likindikoki (S)

School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.

Haneefa T Saleem (HT)

Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH